Two inexpensive classes of drugs available in generic form each reduce the recurrence of breast cancer in post-menopausal women as well as death rates from the disease, a pair of studies reported Friday.
Taking the medications together may further boost anti-cancer benefits and help cancel out undesirable side-effects of one of the drugs, according to the research published in medical journal The Lancet.
The first "meta-study" pulling together data from nine trials covering 30,000 post-menopausal women found endocrine treatments based on a class of drugs called aromatase inhibitors yield higher survival rates after five years compared to standard endocrine therapy with tamoxifen.
The likelihood of cancer recurring was cut by about a third and the risk of dying by about 15 percent in the decade after treatment started. Compared to no treatment at all, the danger of dying from breast cancer fell by 40 percent, the study found.
Most women have already passed through menopause when breast cancer strikes. Even after surgery has removed all detectable traces, tiny amounts of the body's own hormones can cause cancer cells to grow.
Endocrine therapies are designed to impede these hormones from stimulating the disease, and so help protect against relapse.
"But aromatase inhibitor treatment is not free of side-effects and it's important to ensure that women" who suffer them are "supported", said the study's lead author, Mitch Dowsett of The Institute of Cancer Research in London.
The second meta-study, which scanned the results of 26 trials involving another 20,000 women, showed that another class of drugs called bisphosphonates -- usually taken to treat osteoporosis, a bone-weakening condition that becomes more common with age -- also significantly boosted survival when taken for at least two years.
When breast cancer spreads, bone is its favoured destination. Tumour cells released from the primary breast cancer can remain dormant in bones for years before moving to other parts of the body.
Bisphosphonates make the bones a less hospitable environment for the cancer cells and so reduce the risk of cancer recurring. The beneficial effect were found to be far more pronounced in post-menopausal women, regardless of the treatment duration, the size of the tumour or whether the cancer had spread to lymph nodes.
The therapy did not, however, reduce the risk of new cancers developing in the opposite breast.
"These simple, well-tolerated treatments should now be considered for routine use" in women with natural or medically induced menopause, lead author Robert Coleman from the University of Sheffield said in a statement.
Some two-thirds of all women with breast cancer are post-menopausal with hormone-sensitive tumours, so could potentially benefit from both drugs, the researchers conclude.
"The drugs are complementary," noted Oxford University's Richard Gray, lead statistician for the studies. "The main side effect of aromatase inhibitors is an increase in bone loss and fractures, while bisphosphonates reduce bone loss."
AFP RELAXNEWS
Fri Jul 24 2015
A study found that taking the medications together may further boost anti-cancer benefits.
Bekas CEO 7-Eleven, Hishammudin Hasan dilantik terajui Al-Ikhsan
Al-Ikhsan Sports Sdn Bhd melantik Datuk Hishammudin Hasan sebagai ketua pegawai eksekutif (CEO) baharunya berkuat kuasa 17 April.
'Inflasi diunjur meningkat suku kedua kesan pelarasan cukai perkhidmatan, rasionalisasi subsidi'
Momentum inflasi diunjur meningkat pada suku kedua tahun ini kesan daripada pelarasan cukai perkhidmatan serta rasionalisasi subsidi bahan api.
Kontroversi UM: Sarjana ‘berkualiti rendah’ tak patut dijemput - PM Anwar
Anwar menyindir ahli akademik AS yang terbabit dalam kontroversi pro-Israel sebagai sarjana berkualiti rendah dan tidak mempunyai pencapaian luar biasa atau istimewa.
Agong, Raja Permaisuri zahir ucapan Ulang Tahun Keputeraan kepada Sultan Terengganu
Ucapan itu dizahirkan Seri Paduka Baginda berdua menerusi poster yang dimuat naik di Facebook Sultan Ibrahim Sultan Iskandar hari ini.
Ada wajah kita tak mahu berpisah, tapi terpaksa melepaskannya - Datuk Red
Menerusi perkongsian itu, Adnan mengatakan ada perkara yang dia terpaksa reda dan menerima takdir yang sudah tertulis untuknya.
Komen jelik nahas helikopter Lumut, peniaga didenda RM23,000
Seorang peniaga dalam talian didenda RM23,000 di Mahkamah Sesyen di sini, selepas mengaku bersalah atas tuduhan memuat naik komen jelik berhubung nahas helikopter TLDM.
Bursa Malaysia dibuka rendah, jejaki prestasi Wall Street
Pada 9.10 pagi, FTSE Bursa Malaysia KLCI (FBM KLCI) susut 2.29 mata kepada 1,566.96 daripada 1,569.25 ketika ditutup pada Khamis.
AWANI Ringkas: Pesawat ringan mendarat cemas di Subang
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Cambodia Airways mulakan penerbangan terus Phnom Penh-Kuala Lumpur
Syarikat penerbangan Kemboja, Cambodia Airways, secara rasmi memulakan penerbangan terus dari ibu negaranya, Phnom Penh ke KLIA pada Khamis.
Semangat baharu bina ekosistem inovasi lebih dinamik
Perbadanan Pembangunan Teknologi Malaysia, MTDC meneruskan kesinambungan dalam memacu pembangunan teknologi negara, dengan melancarkan Citra MTDC, untuk mewujudkan ekosistem inovasi yang lebih dinamik.